Lfb Group Is A French Biopharmaceutical Company That Specializes In Plasma Derived Medicinal Products And Recombinant Proteinsthe Company Focuses On Treating Serious And Rare Diseasesparticularly In The Areas Of Hemostasisimmunologyand Intensive Careestablished As A Public Interest Grouplfb Operates Globally With Subsidiaries In The U S Germanyspainbelgiumand The Ukemploying Over 2 900 People And Reporting A 526 1 Million In Sales For 2023 Lfb S Product Portfolio Includes Immunoglobulinsfibrinogenand Clotting Factorsas Well As Advanced Therapies Like Cell And Gene Therapy Through Its Cellforcure Platformthe Company Collaborates With International Partners For Plasma Collection And Fractionationensuring A Robust Manufacturing Processlfb Has Expanded Its Reach Through Acquisitions And Partnershipssecuring Market Access In Approximately 30 Countriesthe Company Is Committed To Innovationinvesting In Biotechnology Advancements And Focusing On Next Generation Therapies
No conferences found for this company.
| Company Name | Laboratoire Francais Du Fractionnement Et Des Biotechnologies Lfb Sas |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
